Trulieve Cannabis Analyst Ratings
Trulieve Cannabis Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/09/2023 | 30.52% | Needham | $9 → $6.5 | Maintains | Buy |
08/11/2023 | 20.48% | Wedbush | $8 → $6 | Maintains | Outperform |
08/10/2023 | 80.72% | Needham | $10 → $9 | Maintains | Buy |
05/10/2023 | 100.8% | Needham | $12 → $10 | Maintains | Buy |
03/09/2023 | 140.96% | Needham | $14.25 → $12 | Maintains | Buy |
03/09/2023 | 642.97% | Cantor Fitzgerald | $41 → $37 | Maintains | Overweight |
03/06/2023 | 723.29% | Cantor Fitzgerald | $51 → $41 | Maintains | Overweight |
12/02/2022 | 261.45% | Wedbush | → $18 | Initiates Coverage On | → Outperform |
11/10/2022 | 924.1% | Cantor Fitzgerald | $54 → $51 | Maintains | Overweight |
08/11/2022 | 984.34% | Cantor Fitzgerald | $57 → $54 | Maintains | Overweight |
07/22/2022 | 361.85% | Seaport Global | → $23 | Initiates Coverage On | → Buy |
05/13/2022 | 1044.58% | Cantor Fitzgerald | $59 → $57 | Maintains | Overweight |
03/31/2022 | 843.78% | Needham | $50 → $47 | Maintains | Buy |
03/29/2022 | 1104.82% | Cantor Fitzgerald | $72 → $60 | Maintains | Overweight |
02/18/2022 | 904.02% | Needham | $54 → $50 | Maintains | Buy |
01/07/2022 | — | Wolfe Research | Initiates Coverage On | → Outperform | |
12/06/2021 | 1345.78% | Cantor Fitzgerald | $73 → $72 | Maintains | Overweight |
11/03/2021 | 1365.86% | Cantor Fitzgerald | $77 → $73 | Maintains | Overweight |
09/22/2021 | 1526.51% | Cantor Fitzgerald | $50.5 → $81 | Maintains | Overweight |
08/05/2021 | 1270.48% | Needham | $62.25 → $68.25 | Maintains | Buy |
07/07/2021 | 1144.98% | Jefferies | → $62 | Initiates Coverage On | → Buy |
05/14/2021 | 1325.7% | Cantor Fitzgerald | $76 → $71 | Maintains | Overweight |
05/10/2021 | 1426.1% | Cantor Fitzgerald | $89 → $76 | Maintains | Overweight |
04/30/2021 | 1687.15% | Cantor Fitzgerald | $83 → $89 | Maintains | Overweight |
03/24/2021 | 1119.88% | Needham | $60.5 → $60.75 | Maintains | Buy |
02/04/2021 | 1104.82% | Roth Capital | → $60 | Initiates Coverage On | → Buy |
11/17/2020 | 1165.06% | Cantor Fitzgerald | $60 → $63 | Maintains | Overweight |
09/17/2020 | 1104.82% | Cantor Fitzgerald | $59 → $60 | Maintains | Overweight |
08/04/2020 | 487.35% | Needham | $18.2 → $29.25 | Maintains | Buy |
06/30/2020 | 944.18% | Cantor Fitzgerald | $50 → $52 | Maintains | Overweight |
05/21/2020 | 265.46% | Needham | $17.2 → $18.2 | Maintains | Buy |
05/13/2020 | 245.38% | Needham | $15.5 → $17.2 | Maintains | Buy |
04/09/2020 | 211.24% | Needham | $15.25 → $15.5 | Maintains | Buy |
04/06/2020 | 502.41% | Cantor Fitzgerald | $32 → $30 | Maintains | Overweight |
03/23/2020 | 206.22% | Needham | $20 → $15.25 | Maintains | Buy |
02/14/2020 | 502.41% | Cantor Fitzgerald | → $30 | Initiates Coverage On | → Overweight |
12/16/2019 | 301.61% | Craig-Hallum | → $20 | Initiates Coverage On | → Buy |
12/03/2019 | 301.61% | Needham | → $20 | Initiates Coverage On | → Buy |
12/02/2019 | 241.37% | Compass Point | $11 → $17 | Upgrades | Neutral → Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
11/09/2023 | 30.52% | 尼德姆 | 9 美元 → 6.5 美元 | 維護 | 買 |
08/11/2023 | 20.48% | Wedbush | 8 美元 → 6 美元 | 維護 | 跑贏大盤 |
08/10/2023 | 80.72% | 尼德姆 | 10 美元 → 9 美元 | 維護 | 買 |
05/10/2023 | 100.8% | 尼德姆 | 12 美元 → 10 美元 | 維護 | 買 |
03/09/2023 | 140.96% | 尼德姆 | 14.25 美元 → 12 美元 | 維護 | 買 |
03/09/2023 | 642.97% | 坎託·菲茨傑拉德 | 41 美元 → 37 美元 | 維護 | 超重 |
03/06/2023 | 723.29% | 坎託·菲茨傑拉德 | 51 美元 → 41 美元 | 維護 | 超重 |
12/02/2022 | 261.45% | Wedbush | → 18 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
2022 年 10 月 11 日 | 924.1% | 坎託·菲茨傑拉德 | 54 美元 → 51 美元 | 維護 | 超重 |
08/11/2022 | 984.34% | 坎託·菲茨傑拉德 | 57 美元 → 54 美元 | 維護 | 超重 |
07/22/2022 | 361.85% | 海港全球 | → 23 美元 | 啓動覆蓋範圍開啓 | → 購買 |
05/13/2022 | 1044.58% | 坎託·菲茨傑拉德 | 59 美元 → 57 美元 | 維護 | 超重 |
03/31/2022 | 843.78% | 尼德姆 | 50 美元 → 47 美元 | 維護 | 買 |
03/29/2022 | 1104.82% | 坎託·菲茨傑拉德 | 72 美元 → 60 美元 | 維護 | 超重 |
2022 年 2 月 18 日 | 904.02% | 尼德姆 | 54 美元 → 50 美元 | 維護 | 買 |
2022 年 7 月 1 日 | — | 沃爾夫研究 | 啓動覆蓋範圍開啓 | → 跑贏大盤 | |
12/06/2021 | 1345.78% | 坎託·菲茨傑拉德 | 73 美元 → 72 美元 | 維護 | 超重 |
11/03/2021 | 1365.86% | 坎託·菲茨傑拉德 | 77 美元 → 73 美元 | 維護 | 超重 |
2021 年 9 月 22 日 | 1526.51% | 坎託·菲茨傑拉德 | 50.5 美元 → 81 美元 | 維護 | 超重 |
08/05/2021 | 1270.48% | 尼德姆 | 62.25 美元 → 68.25 美元 | 維護 | 買 |
2021 年 7 月 7 日 | 1144.98% | 傑富瑞集團 | → 62 美元 | 啓動覆蓋範圍開啓 | → 購買 |
05/14/2021 | 1325.7% | 坎託·菲茨傑拉德 | 76 美元 → 71 美元 | 維護 | 超重 |
2021 年 10 月 5 日 | 1426.1% | 坎託·菲茨傑拉德 | 89 美元 → 76 美元 | 維護 | 超重 |
04/30/2021 | 1687.15% | 坎託·菲茨傑拉德 | 83 美元 → 89 美元 | 維護 | 超重 |
2021 年 3 月 24 日 | 1119.88% | 尼德姆 | 60.5 美元 → 60.75 美元 | 維護 | 買 |
02/04/2021 | 1104.82% | 羅斯資本 | → 60 美元 | 啓動覆蓋範圍開啓 | → 購買 |
2020 年 11 月 17 日 | 1165.06% | 坎託·菲茨傑拉德 | 60 美元 → 63 美元 | 維護 | 超重 |
09/17/2020 | 1104.82% | 坎託·菲茨傑拉德 | 59 美元 → 60 美元 | 維護 | 超重 |
08/04/2020 | 487.35% | 尼德姆 | 18.2 美元 → 29.25 美元 | 維護 | 買 |
06/30/2020 | 944.18% | 坎託·菲茨傑拉德 | 50 美元 → 52 美元 | 維護 | 超重 |
05/21/2020 | 265.46% | 尼德姆 | 17.2 美元 → 18.2 美元 | 維護 | 買 |
05/13/2020 | 245.38% | 尼德姆 | 15.5 美元 → 17.2 美元 | 維護 | 買 |
04/09/2020 | 211.24% | 尼德姆 | 15.25 美元 → 15.5 美元 | 維護 | 買 |
2020 年 6 月 4 日 | 502.41% | 坎託·菲茨傑拉德 | 32 美元 → 30 美元 | 維護 | 超重 |
03/23/2020 | 206.22% | 尼德姆 | 20 美元 → 15.25 美元 | 維護 | 買 |
02/14/2020 | 502.41% | 坎託·菲茨傑拉德 | → 30 美元 | 啓動覆蓋範圍開啓 | → 超重 |
2019 年 12 月 16 日 | 301.61% | Craig-Hallum | → 20 美元 | 啓動覆蓋範圍開啓 | → 購買 |
2019 年 3 月 12 日 | 301.61% | 尼德姆 | → 20 美元 | 啓動覆蓋範圍開啓 | → 購買 |
12/02/2019 | 241.37% | 羅盤點 | 11 美元 → 17 美元 | 升級 | 中性 → 買入 |
What is the target price for Trulieve Cannabis (TCNNF)?
Trulieve Cannabis(TCNNF)的目標價格是多少?
The latest price target for Trulieve Cannabis (OTCQX: TCNNF) was reported by Needham on November 9, 2023. The analyst firm set a price target for $6.50 expecting TCNNF to rise to within 12 months (a possible 30.52% upside). 9 analyst firms have reported ratings in the last year.
Needham於2023年11月9日公佈了Trulieve Cannabis(場外交易代碼:TCNNF)的最新目標價格。該分析公司將目標股價定爲6.50美元,預計TCNNF將在12個月內升至12個月內(可能上漲30.52%)。去年有9家分析公司公佈了評級。
What is the most recent analyst rating for Trulieve Cannabis (TCNNF)?
分析師對Trulieve Cannabis(TCNNF)的最新評級是多少?
The latest analyst rating for Trulieve Cannabis (OTCQX: TCNNF) was provided by Needham, and Trulieve Cannabis maintained their buy rating.
Trulieve Cannabis(場外交易代碼:TCNNF)的最新分析師評級由Needham提供,Trulieve Cannabis維持買入評級。
When is the next analyst rating going to be posted or updated for Trulieve Cannabis (TCNNF)?
Trulieve Cannabis(TCNNF)的下一個分析師評級何時公佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Trulieve Cannabis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Trulieve Cannabis was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與Trulieve Cannabis的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。Trulieve Cannabis的最新評級是在2023年11月9日公佈的,因此您應該預計下一個評級將在2024年11月9日左右公佈。
Is the Analyst Rating Trulieve Cannabis (TCNNF) correct?
分析師對 Trulieve Cannabis (TCNNF) 的評級正確嗎?
While ratings are subjective and will change, the latest Trulieve Cannabis (TCNNF) rating was a maintained with a price target of $9.00 to $6.50. The current price Trulieve Cannabis (TCNNF) is trading at is $4.98, which is out of the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但最新的Trulieve Cannabis(TCNNF)評級維持不變,目標股價爲9.00美元至6.50美元。Trulieve Cannabis(TCNNF)目前的交易價格爲4.98美元,超出了分析師的預期區間。